ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Carcinoma
Neoplasm Metastasis

Non-Small-Cell Lung Cancer trials near San Francisco, CA, USA:

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...

Active, not recruiting
Stage IA Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Procedure: Therapeutic Conventional Surgery
Drug: Osimertinib

Phase 2

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 2 other locations

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Stanford, California, United States and 25 other locations

This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...

Enrolling
Non-Small Cell Lung Cancer
Drug: Ramucirumab
Drug: Rilvegostomig

Phase 2

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 56 other locations

of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...

Active, not recruiting
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Drug: Erlotinib 150/100 mg
Drug: AZD9291 80 mg/40 mg + placebo

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 169 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

San Francisco, California, United States and 294 other locations

in subjects with locally advanced and unresectable or metastatic non-small cell lung cancer with a KRAS ...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Lung Carcinoma
Drug: BBO-8520
Drug: Pembrolizumab

Phase 1

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

San Francisco, California, United States and 20 other locations

in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or ho....

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: Abemaciclib
Drug: Anastrozole

Phase 1

Lilly
Lilly

San Francisco, California, United States and 23 other locations

checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC tumors at multiple study sites. The main objectives of the study are to ...

Enrolling
Non Small Cell Lung Cancer
Drug: [18F]F AraG

Phase 2

CellSight Technologies

Palo Alto, California, United States and 2 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 152 other locations

of adult participants with KRAS G12C-mutated, advanced or metastatic non squamous non-small cell lung ca...

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Cisplatin
Drug: Pemetrexed

Phase 3

Roche
Roche

Greenbrae, California, United States and 62 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems